The end of the talk ...

• Methods to derive pertinent PK/PD parameters

• Data with selected existing antibiotics

• What does Industry do ?(but they may not tell you…)

• What can Regulatory Bodies require ?

Previous slide

Next slide

Back to first slide

View graphic version